Journey Medical Corporation Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

REVENUES FROM CONTRACTS WITH CUSTOMERS - Significant customers (Details)

REVENUES FROM CONTRACTS WITH CUSTOMERS - Significant customers (Details) - Customer concentration risk - customer	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Product revenue \| Customer
REVENUES FROM CONTRACTS WITH CUSTOMERS
Number of customers	0	0	0	0
Accounts receivable \| Customer
REVENUES FROM CONTRACTS WITH CUSTOMERS
Number of customers			0
Accounts receivable \| One customer
REVENUES FROM CONTRACTS WITH CUSTOMERS
Number of customers					1
Concentration risk, percentage					10.30%

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References + Details